vimarsana.com

Component Summary News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Worse Outcomes Seen for Severe Bilateral Hip OA in Adult Spinal Deformity

For patients with adult spinal deformity (ASD), those with severe bilateral hip osteoarthritis (OA) have worse outcomes.

East providenceRhode islandUnited statesBasselg dieboWarren alpert medical school of brown universityHealthday newsWarren alpert medical schoolBrown universityComponent summaryDepuy synthes spine

Shockwave Therapy Shows Benefit in Lower Limb Claudication

Sessions improved physical function and walking distance at 12 weeks

New yorkUnited statesFrance generalHelen potterLinda harrisJacobs school of medicineHull york medical schoolBiomedical sciences in buffaloPhysical functioningParis caiJacobs schoolBiomedical sciencesShockwave therapyLower limb intermittent calf claudicationComponent summary

Intravenous Secukinumab Demonstrates Long-Term Safety and Efficacy for Active Axial Spondyloarthritis

Treatment with IV SEC demonstrated safety and efficacy through 52 weeks among adult patients with active axSpA.

United statesSan diegoAmerican college of rheumatologyAmerican collegeAnkylosing spondylitis disease activity scoreBath ankylosing spondylitis functional indexShort formComponent summary

Tofacitinib-Treated Women With PsA Less Likely to Achieve MDA

At month 3, patients treated with tofacitinib achieved higher rates of ACR20/50, MDA, and PASI75 in both sexes when compared with the placebo. However, female patients were less likely to achieve MDA when compared with males.

Women college research institute lihi ederAmerican college of rheumatologyWomen college research instituteUniversity of torontoHealth assessment questionnaireCollege research instituteLihi ederPsoriasis area severity indexAmerican collegeHealth assessment questionnaire disability indexPatient global assessmentDisease activityComponent summaryFunctional assessmentChronic illness therapy fatigue

Outcomes in Nontransfusion-Dependent β-Thalassemia With Luspatercept or Placebo

Researchers determined luspatercept may improve outcomes in patients with nontransfusion-dependent β-thalassemia.

United statesAntonis kattamisAmerican society of hematologyItem short form health surveyUniversity of athensAmerican societyAnnual meetingReported outcomesComponent summaryPatient global impression

vimarsana © 2020. All Rights Reserved.